Lerodalcibep is approved in the EU under the brand name Lyrokaul for the treatment of adult patients with ...

Research Director, Vyansa Intelligence highlights that the next phase of AI adoption in Indian pharma will depend not on ...

Global pharma major, Lupin announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its New Drug Application for Apixaban Oral Suspension […] ...

Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin ...

Corporate history is replete with examples of the ‘third generation curse’, but the Daftary family seem to be bucking that ...

Shilpa Biologicals, an integrated biologics development and manufacturing organisation, announces an exclusive Middle East ...

Alkem Laboratories announced the launch of NeuCeno (cenobamate), anti-seizure medication (ASM) for the treatment of ...

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it has signed a non-exclusive license agreement ...

Innovation is often measured through rankings, patents and startup success stories. While these are important indicators, ...

A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extolled the benefits of the QR barcoding programme ...

For much of the past two decades, global biotech leadership has clustered around a handful of hubs, each anchored by patient ...

Manoj Joshi, Secretary, Department of Pharmaceuticals, Government of India, visited Amneal Pharmaceuticals’ corporate office ...